These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 6371215)
1. [Examination of phenytoin metabolites in rat urine]. Izumo Y; Sato A; Shimada K; Sakaguchi T; Okabayashi I; Murakami N Yakugaku Zasshi; 1983 Sep; 103(9):956-61. PubMed ID: 6371215 [No Abstract] [Full Text] [Related]
2. Urinary dihydrodiol metabolites of phenytoin: high-performance liquid chromatographic assay of diastereomeric composition. Maguire JH; Wilson DC J Chromatogr; 1985 Aug; 342(2):323-32. PubMed ID: 4055953 [TBL] [Abstract][Full Text] [Related]
3. Direct high-performance liquid chromatographic analysis of p-hydroxyphenyl-phenylhydantoin glucuronide, the final metabolite of phenytoin, in human serum and urine. Vree TB; Steegers-Theunissen RP; Baars AM; Hekster YA J Chromatogr; 1990 Apr; 526(2):581-9. PubMed ID: 2362000 [No Abstract] [Full Text] [Related]
4. Separation of phenytoin and its metabolites by high-performance liquid chromatography. Chow SA; Charkowski DM; Fischer LJ Life Sci; 1980 Dec 22-29; 27(25-26):2477-82. PubMed ID: 7219021 [No Abstract] [Full Text] [Related]
5. Evidence for stereoselective production of phenytoin (5,5-diphenylhydantoin) arene oxides in man. Maguire JH; McClanahan JS Adv Exp Med Biol; 1986; 197():897-902. PubMed ID: 3766299 [No Abstract] [Full Text] [Related]
6. 5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human. Thompson RM; Beghin J; Fife WK; Gerber N Drug Metab Dispos; 1976; 4(4):349-56. PubMed ID: 8289 [TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic determination of the enantiomeric composition of urinary phenolic metabolites of phenytoin. McClanahan JS; Maguire JH J Chromatogr; 1986 Sep; 381(2):438-46. PubMed ID: 3760100 [No Abstract] [Full Text] [Related]
8. Isolation and determination of the diastereomers of the glucuronidated 5-(4-hydroxyphenyl)-5-phenylhydantoin in human urine using HPLC. Hermansson J; Iversen T; Lindquist U Acta Pharm Suec; 1982; 19(3):199-210. PubMed ID: 7113727 [No Abstract] [Full Text] [Related]
9. Liquid-chromatographic method for simultaneous determination of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in plasma and urine. Sawchuk RJ; Cartier LL Clin Chem; 1980 Jun; 26(7):835-9. PubMed ID: 7379305 [TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic determination of phenytoin and hydroxyphenytoin in human urine. Sato A; Shimada K; Izumo Y; Sakaguchi T J Chromatogr; 1983 Jun; 275(1):97-105. PubMed ID: 6874875 [TBL] [Abstract][Full Text] [Related]
11. Spectroscopic determination of the major metabolite of phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin in human urine. Moustafa MA; Belal F; el-Emam AA J Pharm Belg; 1987; 42(1):53-8. PubMed ID: 3585688 [No Abstract] [Full Text] [Related]
12. Analysis of p-hydroxyphenytoin in microsomal reactions by high-performance liquid chromatography with electrochemical detection. Kapetanovic IM; Kupferberg HJ J Chromatogr; 1984 Oct; 310(2):418-23. PubMed ID: 6511859 [No Abstract] [Full Text] [Related]
13. Absolute configurations of the dihydrodiol metabolites of 5,5-diphenylhydantoin (phenytoin) from rat, dog, and human urine. Maguire JH; Butler TC; Dudley KH Drug Metab Dispos; 1980; 8(5):325-31. PubMed ID: 6107230 [TBL] [Abstract][Full Text] [Related]
14. Comparative study on the para-metabolic oxidation of phenytoin and decadeuteriophenytoin. Moustafa MA; el-Emam AA; Subbagh HI; el-Din MK Arzneimittelforschung; 1990 Oct; 40(10):1076-8. PubMed ID: 2291743 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of p-hydroxylated and dihydrodiol metabolites of phenytoin in urine by high-performance liquid chromatography. Szabo GK; Pylilo RJ; Davoudi H; Browne TR J Chromatogr; 1990 Dec; 535(1-2):279-85. PubMed ID: 2089057 [TBL] [Abstract][Full Text] [Related]
17. Extent of urinary excretion of p-hydroxyphenytoin in healthy subjects given phenytoin. Dickinson RG; Hooper WD; Patterson M; Eadie MJ; Maguire B Ther Drug Monit; 1985; 7(3):283-9. PubMed ID: 4049465 [TBL] [Abstract][Full Text] [Related]
18. Thin-layer chromatographic analysis of phenytoin and its hydroxy metabolites. Rao GS; McLennon DA J Chromatogr; 1977 Jul; 137(1):231-3. PubMed ID: 893586 [No Abstract] [Full Text] [Related]
19. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man. Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920 [TBL] [Abstract][Full Text] [Related]
20. [High performance liquid chromatographic determination of hydroxyphenytoin in human urine]. Zeng J; Liu D; Zou Y Hua Xi Yi Ke Da Xue Xue Bao; 1992 Sep; 23(3):321-4. PubMed ID: 1298726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]